TY  - JOUR
AU  - Pérez-Stachowski, Javier
AU  - Tortajada, Begoña
AU  - Del Arco, Alfonso
AU  - Márquez, Efrén
AU  - De la Torre, Javier
AU  - Nieto, Miriam
AU  - García de Lomas, José María
AU  - Prada, José Luis
AU  - García-Alegría, Javier
AU  - Olalla, Julián
PY  - 2019
DO  - 10.1080/23744235.2019.1637536
UR  - https://hdl.handle.net/10668/26684
T2  - Infectious diseases (London, England)
AB  - Introduction: Generic drugs are helpful to enhance the efficiency of the sanitary system. A generic coformulation of abacavir (ABC) and lamivudine (3TC) is available since 2016 in Spain. A report of our experience with its use is exposed. Methods:...
LA  - en
KW  - Dolutegravir
KW  - HIV
KW  - antiretroviral treatment
KW  - drugs
KW  - generic
KW  - switch
KW  - Anti-HIV Agents
KW  - Dideoxynucleosides
KW  - Drug Combinations
KW  - Drug Substitution
KW  - Drugs, Generic
KW  - Female
KW  - HIV Infections
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Spain
TI  - Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks.
TY  - research article
VL  - 51
ER  -